Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: Physicochemical properties that regulate penetration of quinolone antimicrobials

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1417-1423

  Liu, Weiguo ^a   Liu, Qing Feng ^a   Perkins, Ruth ^a   Drusano, George ^a   Louie, Arnold ^a   Madu, Assumpta ^b   Mian, Umar ^b   Mayers, Martin ^b   Miller, Michael H ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; FLEROXACIN; OFLOXACIN; PROBENECID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ADOLESCENT; ARTICLE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG PENETRATION; DRUG PROTEIN BINDING; INTRAOCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIPOPHILICITY; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RABBIT; REGRESSION ANALYSIS; STAPHYLOCOCCUS EPIDERMIDIS; VITREOUS BODY;

EID: 0344074584     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1417     Document Type: Article

References (62)

1. Akaike, H. A. 1973. A new look at the statistical model identification. IEEE 19:716-723.
2. Bacon, A. S., C. R. Davison, B. C. Patel, D. G. Frazer, L. A. Ficker, and J. K. Dart. 1993. Infective endophthalmitis following vitreoretinal surgery. Eye 7: 529-534.
3. Barza, M., R. B. Brown, C. Shanks, C. Gamble, and L. Weinstein. 1975. Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob. Agents Chemother. 8:713-720.
4. Barza, M., A. Kane, and J. Baum. 1982. The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor. Investig. Ophthalmol. Vis. Sci. 22:720-726.
5. Barza, M., A. Kane, and J. Baum. 1983. Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys. Investig. Ophthalmol. Vis. Sci. 24:1602-1606.
6. Barza, M., and G. Cuchural. 1985. General principles of antibiotic tissue penetration. J. Antimicrob. Chemother. 15(Suppl. A):59-75.
7. Barza, M. 1989. Antibacterial agents in the treatment of ocular infections. Infect. Dis. Clin. North Am. 3:533-551.
8. Barza, M., E. Lynch, and J. L. Baum. 1993. Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbit. Arch. Ophthalmol. 111:121-125.
9. Bito, L. Z., and C. J. DeRousseau. 1980. Transport functions of the blood-retinal barrier system and the micro-environment of the retina. NATO Adv. Study Inst. Ser. Ser. A Life Sci. 32:133-163.
10. Bleeker, G. M., N. J. van Haeringen, and E. Glasius. 1968. Urea and the vitreous barrier of the eye. Exp. Eye Res. 7:30-36.
11. Borner, K., E. Borner, and H. Lode. 1992. Determination of sparfloxacin in serum and urine by high-performance liquid chromatography. J. Chromatogr. 579:285-289.
12. Broughton, W., and J. N. Goldman. 1973. The intraocular penetration of chloramphenicol succinate in rabbits. Ann. Ophthalmol. 5:71-74.
13. Burns-Bellhorn, M. S., R. W. Bellhorn, and J. V. Benjamin. 1978. Anterior segment permeability to fluorescein-labeled dextrans in the rat. Investig. Ophthalmol. Vis. Sci. 17:857-862.
14. Canton, E., J. Peman, M. T. Jimenez, M. S. Ramon, and M. Gobernado. 1992. In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrob. Agents Chemother. 36:558-565.
15. Chapman, J. S., and N. H. Georgopapadakou. 1988. Routes of quinolone permeation in Escherichia coli. Antimicrob. Agents Chemother. 32:438-442.
16. Cochereau-Massin, I., J. Bauchet, S. Marrakchi-Benjaafar, A. Saleh-Mghir, F. Faurisson, J. M. Vallois, E. Vallee, and J. J. Pocidalo. 1993. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrob. Agents Chemother. 37:633-636.
17. Cornford, E. M., L. D. Braun, W. H. Oldendorf, and M. A. Hill. 1982. Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults. Am. J. Physiol. 243:C161-C168.
18. Cunha-Vaz, J. G., and D. M. Maurice. 1967. The active transport of fluorescein by the retinal vessels and the retina. J. Physiol. (London) 191:467-486.
19. Davson, H. 1990. Physiology of the eye, 5th ed. Pergamon Press, New York, N.Y.
20. Davson, H., K. Welch, and M. B. Segal. 1987. Physiology and pathophysiology of the cerebrospinal fluid. Churchill Livingston, New York, N.Y.
21. Donahue, S. P., R. P. Kowalski, A. W. Eller, J. M. De Varo, and B. H. Jewart. 1994. Empiric treatment of endophthalmitis. Are aminoglycosides necessary? Arch. Ophthalmol. 112:45-47.
22. Driebe, W. T., Jr., S. Mandelbaum, R. K. Forster, L. K. Schwartz, and W. W. Culbertson. 1986. Pseudophakic endophthalmitis. Diagnosis and management. Ophthalmology 93:442-448.
23. Drusano, G. L., W. Liu, R. Perkins, A. Madu, C. Madu, M. Mayers, and M. H. Miller. 1995. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program. Antimicrob. Agents Chemother. 39:1683-1687.
24. Endophthalmitis Vitrectomy Study Group. 1995. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch. Ophthalmol. 113:1479-1496.
25. Ficker, L., T. A. Meredith, S. Gardner, and L. A. Wilson. 1990. Cefazolin levels after intravitreal injection: effects of inflammation and surgery. Investig. Ophthalmol. Vis. Sci. 31:502-505.
26. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, vol. 15. Drugs and the pharmaceutical sciences, 2nd ed. Marcel Dekker, New York, N.Y.
27. Grasela, T. H., Jr. 1986. Population pharmacokinetics: application to clinical trials, p. 85-103. In R. B. Smith, P. D. Kroboth, and R. P. Juhl (ed.), Pharmacokinetics and pharmacodynamics: research design and analysis. Harvey Whitney Books, Cincinnati, Ohio.
28. Hirai, K., H. Aoyama, T. Irikura, S. Iyobe, and S. Mitsuhashi. 1986. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob. Agents Chemother. 29: 535-538. (Erratum, 30:342.)
29. Jaehde, U., F. Sorgel, A. Reiter, G. Sigl, K. G. Naber, and W. Schunack. 1995. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Clin. Pharmacol. Ther. 58:532-541.
30. Johnson, J. H., M. A. Cooper, J. M. Andrews, and R. Wise. 1992. Pharmacokinetics and inflammatory fluid penetration of sparfloxacin. Antimicrob. Agents Chemother. 36:2444-2446.
31. Kitaura, T., S. Tsukiai, S. Arai, K. Miyake, M. Kimura, and H. Fukuchi. 1988. Ocular pharmacokinetics of latamoxef and cefaclor in rabbits. Penetration into aqueous humor. J. Pharmacobio-Dyn. 11:694-699.
32. Kowalski, R. P., L. M. Karenchak, and A. W. Eller. 1993. The role of ciprofloxacin in endophthalmitis therapy. Am. J. Ophthalmol. 116:695-699.
33. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
34. Lesk, M. R., H. Ammann, G. Marcil, B. Vinet, L. Lamer, and M. Sebag. 1993. The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. Am. J. Ophthalmol. 115:623-628.
35. Madu, A., M. Mayers, R. Perkins, W. Liu, G. Drusano, R. Aswani, C. Madu, and M. Miller. 1996. Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration. Exp. Eye Res. 63: 129-136.
36. Mandell, B. A., T. A. Meredith, E. Aguilar, A. el-Massry, A. Sawant, and S. Gardner. 1993. Effects of inflammation and surgery on amikacin levels in the vitreous cavity. Am. J. Ophthalmol. 115:770-774.
37. Marrakchi, S., I. Cochereau, A. Saleh-Mghir, and J. J. Pocidalo. 1994. Prevention and treatment of experimental staphylococcal endophthalmitis, abstr. B82, p. 173. 3rd International Symposium on New Quinolones.
38. Martin, D. F., L. A. Ficker, H. A. Aguilar, S. K. Gardner, L. A. Wilson, and T. A. Meredith. 1990. Vitreous cefazolin levels after intravenous injection. Effects of inflammation, repeated antibiotic doses, and surgery. Arch. Ophthalmol. 108:411-414.
39. Massin-Cochereau, I., P. Le Hoang, M. Weiser, and F. Rousselie. 1987. Pefloxacin and severe eye infections. Bull. Soc. Ophthalmol. Fr. 87:735-738.
40. Mayers, M., D. Rush, A. Madu, M. Motyl, and M. H. Miller. 1991. Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits. Antimicrob. Agents Chemother. 35:1791-1798.
41. Mayers, M., A. Madu, U. Mian, E. Schwartz, R. Perkins, M. Dezeil, and M. Miller. 1993. Aqueous and vitreous pharmacokinetics of ciprofloxacin and fleroxacin. Investig. Ophthalmol. Vis. Sci. 34:1257.
42. Mayers, M., Y. Garg, U. Mian, G. Newcomer, W. Liu, G. Drusano, and M. H. Miller. 1994. Comparison of fluconazole pharmacokinetics in serum, aqueous, vitreous, and CSF following single dose and serum steady state. Investig. Ophthalmol. Vis. Sci. 35:2216.
43. Miller, M. H., A. Madu, G. Samathanam, D. Rush, C. N. Madu, K. Mathisson, and M. Mayers. 1992. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits. Antimicrob. Agents Chemother. 36:32-38.
44. Moog, E., and H. Knothe. 1969. Passage of various tetracyclines into human aqueous humor in dependence on their protein binding in the blood serum. Ber. Zusammenkunft Dtsch. Ophthalmol. Ges. 69:536-539.
45. Naora, K., Y. Katagiri, K. Iwamoto, K. Tanaka, T. Yamaguchi, and Y. Sekine. 1992. Effect of fenbufen on the pharmacokinetics of sparfloxacin in rats. J. Antimicrob. Chemother. 30:673-683.
46. Nau, R., F. Sorgel, and H. W. Prange. 1994. Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges. J. Neurol. Sci. 122: 61-65.
47. Okano, T., H. Maegawa, K. Inui, and R. Hori. 1990. Interaction of ofloxacin with organic cation transport systems in rat renal brush-border membranes. J. Pharmacol. Exp. Ther. 255:1033-1037.
48. Olson, J. C., H. W. Flynn, Jr., R. K. Forster, and W. W. Culbertson. 1983. Results in the treatment of postoperative endophthalmitis. Ophthalmology 90:692-699.
49. Orbach, E., and A. Finkelstein. 1980. The nonelectrolyte permeability of planar lipid bilayer membranes. J. Gen. Physiol. 75:427-436.
50. Outman, W. R., and C. H. Nightingale. 1989. Metabolism and the fluoroquinolones. Am. J. Med. 87:37S-42S.
51. Perkins, R. J., W. Liu, G. Drusano, A. Madu, M. Mayers, C. Madu, and M. H. Miller. 1995. Pharmacokinetics of ofloxacin in serum and vitreous humor of albino and pigmented rabbits. Antimicrob. Agents Chemother. 39: 1493-1498.
52. Puliafito, C. A., A. S. Baker, J. Haaf, and C. S. Foster. 1982. Infectious endophthalmitis. Review of 36 cases. Ophthalmology 89:921-929.
53. Records, R. E. 1969. The penicillins in ophthalmology. Surv. Ophthalmol. 13: 207-214.
54. Richard, P., and L. Gutmann. 1992. Sparfloxacin and other new fluoroquinolones. J. Antimicrob. Chemother. 30:739-744.
55. Sheiner, B. L., B. Rosenberg, and V. V. Marathe. 1977. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J. Pharmacokinet. Biopharm. 5:445-479.
56. Sheiner, B. L., and S. L. Beal. 1981. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J. Pharmacokinet. Biopharm. 9:635-651.
57. Shiba, K., A. Saito, J. Shimada, S. Hori, M. Kaji, T. Miyahara, H. Kusajima, S. Kaneko, S. Saito, and T. Ooie. 1990. Renal handling of fleroxacin in rabbits, dogs, and humans. Antimicrob. Agents Chemother. 34:58-64.
58. Smith, K. R., and C. G. Cobbs. 1992. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 11: 55-58.
59. Smith, M. A., J. A. Sorenson, F. D. Lowy, J. L. Shakin, W. Harrison, and F. A. Jakobiec. 1986. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin. Ophthalmology 93:1328-1335.
60. Smith, M. A., J. A. Sorenson, C. Smith, M. Miller, and M. Borenstein. 1991. Effects of intravitreal dexamethasone on concentration of intravitreal vancomycin in experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis. Antimicrob. Agents Chemother. 35:1298-1302.
61. Sorensen, P. N. 1971. The penetration of quinine, salicylic acid, PAS, salicyluric acid, barbital and lithium across the vitreous barrier of the rabbit eye. Acta Pharmacol. Toxicol. 29:194-208.
62. Wise, R. 1986. Methods for evaluating the penetration of beta-lactam antibiotics into tissues. Rev. Infect. Dis. 8:S325-S332.